drugset / Trial / NCT00837564

Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic Depression

NCT00837564

RandomizedParallel-groupOpen-labelTreatment

Summary

60 patients with chronic major depressive disorder according to DSM-IV will be included into the study. Patients will be randomized to receive an open treatment either with CBASP, a psychotherapy for chronic depression, or pharmacological treatment with Escitalopram for 28 weeks.

Timeline

Start
2009-02
Primary completion
2010-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg